End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
822.6 INR | -1.37% | +1.26% | +25.19% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.19% | 1.21B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- GLS Stock
- News Glenmark Life Sciences Limited
- Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024